T. Rowe Price Associates’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $146K | Buy |
|
|||||
|
2025
Q2 | $127K | Hold |
|
|||||
|
2025
Q1 | $123K | Buy |
|
|||||
|
2024
Q4 | $107K | Buy |
|
|||||
|
2024
Q3 | $89K | Buy |
|
|||||
|
2024
Q2 | $97K | Buy |
|
|||||
|
2024
Q1 | $66K | Buy |
|
|||||
|
2023
Q4 | $57K | Buy |
|
|||||
|
2023
Q3 | $53K | Buy |
|
|||||
|
2023
Q2 | $76K | Buy |
|
|||||
|
2023
Q1 | $71K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $3.4M | Sell |
|
|||||
|
2014
Q4 | $65.5M | Buy |
|
|||||
|
2014
Q3 | $42.6M | Buy |
|
|||||
|
2014
Q2 | $55.4M | Buy |
|
|||||
|
2014
Q1 | $28.5M | Buy |
|
|||||
|
2013
Q4 | $15M | Buy |
|
|||||
|
2013
Q3 | $255K | Sell |
|
|||||
|
2013
Q2 | $229K | Buy |
|